VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 456 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2014. The put-call ratio across all filers is 0.78 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $89,623,000 | -46.6% | 885,729 | -6.2% | 3.40% | -45.2% |
| Q3 2015 | $167,818,000 | -27.4% | 944,556 | -9.3% | 6.21% | +2.3% |
| Q2 2015 | $231,006,000 | +6.5% | 1,040,887 | -5.2% | 6.07% | +23.5% |
| Q1 2015 | $216,924,000 | +28.1% | 1,098,017 | -6.9% | 4.91% | +37.3% |
| Q4 2014 | $169,396,000 | +12.0% | 1,179,602 | +2.4% | 3.58% | +18.0% |
| Q3 2014 | $151,256,000 | -12.6% | 1,151,863 | -15.7% | 3.03% | -3.7% |
| Q2 2014 | $173,029,000 | -7.2% | 1,365,804 | -3.5% | 3.15% | -7.6% |
| Q1 2014 | $186,491,000 | -2.6% | 1,415,288 | -13.3% | 3.41% | +8.8% |
| Q4 2013 | $191,432,000 | -4.5% | 1,632,133 | -15.0% | 3.13% | +10.1% |
| Q3 2013 | $200,544,000 | -2.2% | 1,919,363 | -19.6% | 2.84% | -7.1% |
| Q2 2013 | $205,134,000 | – | 2,386,480 | – | 3.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,373,210 | $47,796,000 | 39.06% |
| Claren Road Asset Management, LLC | 77,527 | $1,561,000 | 18.46% |
| Okumus Fund Management Ltd. | 4,242,012 | $85,434,000 | 14.79% |
| Chou Associates Management | 1,446,843 | $29,139,000 | 11.12% |
| FARLEY CAPITAL L.P. | 307,458 | $6,192,000 | 9.65% |
| HAP Trading, LLC | 3,129,700 | $112,397,000 | 6.58% |
| Pershing Square Capital Management | 21,591,122 | $434,845,000 | 5.79% |
| NORTH TIDE CAPITAL, LLC | 2,500,000 | $50,350,000 | 5.61% |
| Convector Capital Management, LP | 192,000 | $3,867,000 | 5.34% |
| Nebula Capital Management, LP | 31,770 | $640,000 | 5.07% |